Annual Operating Profit
-$32.13 M
+$4.83 M+13.06%
30 September 2023
Summary:
ESSA Pharma annual operaing income is currently -$32.13 million, with the most recent change of +$4.83 million (+13.06%) on 30 September 2023. During the last 3 years, it has risen by +$5.01 million (+13.49%). EPIX annual operating profit is now -1750.08% below its all-time high of -$1.74 million, reached on 30 September 2014.EPIX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$8.88 M
+$1.83 M+17.08%
30 June 2024
Summary:
ESSA Pharma quarterly operating income is currently -$8.88 million, with the most recent change of +$1.83 million (+17.08%) on 30 June 2024. Over the past year, it has dropped by -$2.13 million (-31.47%). EPIX quarterly operating profit is now -6744.07% below its all-time high of -$129.80 thousand, reached on 31 March 2014.EPIX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$33.95 M
+$200.00 K+0.59%
30 June 2024
Summary:
ESSA Pharma TTM operating income is currently -$33.95 million, with the most recent change of +$200.00 thousand (+0.59%) on 30 June 2024. Over the past year, it has dropped by -$1.88 million (-5.86%). EPIX TTM operating profit is now -14558.64% below its all-time high of -$231.60 thousand, reached on 31 December 2013.EPIX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPIX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -31.5% | -5.9% |
| 3 y3 years | +13.5% | +3.6% | +8.6% |
| 5 y5 years | -164.4% | -174.4% | -179.4% |
EPIX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +13.5% | -31.5% | +22.5% | -6.8% | +14.1% |
| 5 y | 5 years | -164.4% | +13.5% | -174.4% | +25.2% | -179.4% | +14.1% |
| alltime | all time | -1750.1% | +13.5% | -6744.1% | +25.2% | <-9999.0% | +14.1% |
ESSA Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | -$8.88 M(-17.1%) | -$33.95 M(-0.6%) |
| Mar 2024 | - | -$10.71 M(+41.1%) | -$34.15 M(+7.4%) |
| Dec 2023 | - | -$7.59 M(+12.4%) | -$31.80 M(-0.8%) |
| Sept 2023 | -$32.13 M(-13.1%) | -$6.76 M(-25.6%) | -$32.07 M(-1.1%) |
| June 2023 | - | -$9.08 M(+8.6%) | -$32.43 M(-0.6%) |
| Mar 2023 | - | -$8.37 M(+6.4%) | -$32.64 M(-8.7%) |
| Dec 2022 | - | -$7.86 M(+10.4%) | -$35.74 M(-3.3%) |
| Sept 2022 | -$36.96 M(-0.5%) | -$7.12 M(-23.3%) | -$36.96 M(-5.4%) |
| June 2022 | - | -$9.29 M(-19.0%) | -$39.05 M(-0.2%) |
| Mar 2022 | - | -$11.47 M(+26.3%) | -$39.11 M(-1.1%) |
| Dec 2021 | - | -$9.08 M(-1.4%) | -$39.53 M(+6.4%) |
| Sept 2021 | -$37.14 M(+57.9%) | -$9.22 M(-1.4%) | -$37.14 M(+14.8%) |
| June 2021 | - | -$9.35 M(-21.3%) | -$32.36 M(+16.0%) |
| Mar 2021 | - | -$11.88 M(+77.5%) | -$27.89 M(+9.4%) |
| Dec 2020 | - | -$6.69 M(+50.9%) | -$25.49 M(+8.4%) |
| Sept 2020 | -$23.52 M(+93.6%) | -$4.44 M(-9.0%) | -$23.52 M(+5.4%) |
| June 2020 | - | -$4.87 M(-48.6%) | -$22.32 M(+8.3%) |
| Mar 2020 | - | -$9.48 M(+100.6%) | -$20.61 M(+43.7%) |
| Dec 2019 | - | -$4.73 M(+46.0%) | -$14.34 M(+18.1%) |
| Sept 2019 | -$12.15 M | -$3.24 M(+2.3%) | -$12.15 M(+9.9%) |
| June 2019 | - | -$3.16 M(-1.6%) | -$11.05 M(+5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.22 M(+27.0%) | -$10.45 M(-8.4%) |
| Dec 2018 | - | -$2.53 M(+18.5%) | -$11.41 M(+5.6%) |
| Sept 2018 | -$10.80 M(-0.6%) | -$2.14 M(-16.7%) | -$10.80 M(-1.2%) |
| June 2018 | - | -$2.57 M(-38.4%) | -$10.94 M(-13.1%) |
| Mar 2018 | - | -$4.17 M(+116.2%) | -$12.59 M(+2.1%) |
| Dec 2017 | - | -$1.93 M(-15.1%) | -$12.33 M(+13.5%) |
| Sept 2017 | -$10.87 M(-41.9%) | -$2.27 M(-46.2%) | -$10.87 M(-21.2%) |
| June 2017 | - | -$4.22 M(+7.9%) | -$13.78 M(-3.1%) |
| Mar 2017 | - | -$3.91 M(+748.1%) | -$14.23 M(-3.4%) |
| Dec 2016 | - | -$461.30 K(-91.1%) | -$14.74 M(-21.2%) |
| Sept 2016 | -$18.70 M(+82.8%) | -$5.19 M(+11.1%) | -$18.70 M(+25.5%) |
| June 2016 | - | -$4.67 M(+5.6%) | -$14.90 M(+7.3%) |
| Mar 2016 | - | -$4.42 M(-0.2%) | -$13.89 M(+4.3%) |
| Dec 2015 | - | -$4.43 M(+219.8%) | -$13.32 M(+30.2%) |
| Sept 2015 | -$10.23 M(+489.2%) | -$1.38 M(-62.1%) | -$10.23 M(+10.1%) |
| June 2015 | - | -$3.66 M(-5.1%) | -$9.30 M(+41.5%) |
| Mar 2015 | - | -$3.85 M(+187.3%) | -$6.57 M(+130.8%) |
| Dec 2014 | - | -$1.34 M(+198.4%) | -$2.85 M(+63.8%) |
| Sept 2014 | -$1.74 M | -$449.30 K(-51.5%) | -$1.74 M(+34.9%) |
| June 2014 | - | -$927.00 K(+614.2%) | -$1.29 M(+256.5%) |
| Mar 2014 | - | -$129.80 K(-44.0%) | -$361.40 K(+56.0%) |
| Dec 2013 | - | -$231.60 K | -$231.60 K |
FAQ
- What is ESSA Pharma annual operaing income?
- What is the all time high annual operating profit for ESSA Pharma?
- What is ESSA Pharma quarterly operating income?
- What is the all time high quarterly operating profit for ESSA Pharma?
- What is ESSA Pharma quarterly operating profit year-on-year change?
- What is ESSA Pharma TTM operating income?
- What is the all time high TTM operating profit for ESSA Pharma?
- What is ESSA Pharma TTM operating profit year-on-year change?
What is ESSA Pharma annual operaing income?
The current annual operating profit of EPIX is -$32.13 M
What is the all time high annual operating profit for ESSA Pharma?
ESSA Pharma all-time high annual operaing income is -$1.74 M
What is ESSA Pharma quarterly operating income?
The current quarterly operating profit of EPIX is -$8.88 M
What is the all time high quarterly operating profit for ESSA Pharma?
ESSA Pharma all-time high quarterly operating income is -$129.80 K
What is ESSA Pharma quarterly operating profit year-on-year change?
Over the past year, EPIX quarterly operating income has changed by -$2.13 M (-31.47%)
What is ESSA Pharma TTM operating income?
The current TTM operating profit of EPIX is -$33.95 M
What is the all time high TTM operating profit for ESSA Pharma?
ESSA Pharma all-time high TTM operating income is -$231.60 K
What is ESSA Pharma TTM operating profit year-on-year change?
Over the past year, EPIX TTM operating income has changed by -$1.88 M (-5.86%)